Physician profile
Steven Regwan
NPI 1952525123
$131,240.78
in general payments reported to CMS, 2019-2025
46 companies · $22K in 2025
The $22K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $7,731 · 2021: $7,559 · 2022: $2,702 · 2023: $6,991 · 2024: $17K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $14K · Travel and Lodging: $9,778 · Consulting Fee: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,300.00 |
| Food and Beverage | $14,004.66 |
| Travel and Lodging | $9,778.35 |
| Consulting Fee | $937.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $76,208.04 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $26,640.34 | 2019-2025 | Lokelma, Farxiga, Wainua |
| Abbott Laboratories | $13,319.45 | 2019-2025 | Aveir, Triclip, Cardiomems |
| Medtronic, INC. | $4,663.98 | 2021-2025 | Linq II, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $1,740.58 | 2019-2020 | |
| Boston Scientific Corporation | $1,224.99 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $936.71 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $843.67 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $707.58 | 2019-2025 | Lifevest |
| Pfizer INC. | $699.67 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $483.34 | 2022-2025 | Verquvo, Capvaxive |
| Amgen INC. | $451.04 | 2020-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $426.96 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $371.19 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Philips North America LLC | $367.80 | 2022-2025 | (5050) Ext Holter, Extended Holter |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.78 | 2019-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $181.22 | 2023-2025 | Onpattro, Amvuttra |
| Heartflow, INC. | $148.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.62 | 2024-2025 | |
| Edwards Lifesciences Corporation | $137.55 | 2024-2025 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| Mylan Specialty L.P. | $124.20 | 2024 | Yupelri |
| Cardiva Medical, INC. | $112.78 | 2023-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Baxter Healthcare | $99.95 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $92.59 | 2019-2023 | Evkeeza |
| Lundbeck LLC | $79.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $75.43 | 2019-2023 | |
| Inari Medical, INC. | $63.82 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Irhythm Technologies, INC. | $58.20 | 2024 | Zio Xt Patch, Zio Monitor |
| Arbor Pharmaceuticals, INC. | $57.62 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $56.87 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $44.05 | 2022-2023 | Assure Wcd |
| Otsuka America Pharmaceutical, INC. | $38.98 | 2019 | |
| Cordis US Corp. | $36.64 | 2025 | Mynx Control Venous |
| Abiomed | $35.87 | 2025 | |
| Biotronik INC. | $28.11 | 2023-2024 | Biomonitor, Amvia Edge, Edora 8 Dr-T |
| Bridgebio Pharma, INC. | $24.25 | 2025 | Attruby |
| Genzyme Corporation | $22.35 | 2023 | |
| Esperion Therapeutics, INC. | $22.31 | 2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $21.72 | 2024 | Arcalyst |
| Cleerly, INC. | $20.65 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kiniksa Pharmaceuticals, LTD. | $20.61 | 2023 | Arcalyst |
| Penumbra, INC. | $20.07 | 2025 | Indigo System |
| Atricure, INC. | $16.64 | 2024 | |
| Daiichi Sankyo INC. | $15.47 | 2023 | Injectafer |
| W. L. Gore & Associates, INC. | $14.29 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bardy Diagnostics, INC. | $9.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Regwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.